References
- http://ec.europa.eu/eurostat/statistics-explained/index.php/Causes_of_death_statistics (Eurostat Statistic Explained).
- Lee JS, Kovalski G, Sharir T, et al. Advances in imaging instrumentation for nuclear cardiology. J Nucl Cardiol. 2017 Jul 17. DOI:10.1007/s12350-017-0979-8.
- Boellaard R, Quick HH. Current image acquisition options in PET/MR. Semin Nucl Med. 2015;45:192–200. DOI:10.1053/j.semnuclmed.2014.12.001.
- Rischpler C, Nekolla S, Kunze K, et al. PET/MRI of the heart. Semin Nucl Med. 2015;45(3):234–247. DOI:10.1053/j.semnuclmed.2014.12.004.
- Boss A, Weiger M, Wiesinger F. Future image acquisition trends for PET/MRI. Semin Nucl Med. 2015;45(3):201–211. DOI:10.1053/j.semnuclmed.2014.12.002.
- Rager O, Lee-Felker SA, Tabouret-Viaud C, et al. Accuracy of whole-body HDP SPECT/CT, FDG PET/CT, and their combination for detecting bone metastases in breast cancer: an intra-personal comparison. Am J Nucl Med. 2018. Jun 5;8(3):159–168.
- Gajjala SR, Hulikal N, Kadiyala S, et al. Whole-body 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET/CT) for staging locally advanced breast cancer: A prospective study from a tertiary cancer centre in south India. Indian J Med Res. 2018 Mar;147(3):256–262. DOI:10.4103/ijmr.IJMR_1368_16.
- Cremer P, Hachamovitch R, Tamarappoo B. Clinical decision making with myocardial perfusion imaging in patients with known or suspected coronary artery disease. Semin Nucl Med. 2014;44:320–329. DOI:10.1053/j.semnuclmed.2014.04.006.
- Jadvar H, Colletti PM. Competitive advantage of PET/MRI. Eur J Radiol. 2014;83:84–94. doi: 10.1016/j.ejrad.2013.05.028
- Masuda A, Nemoto A, Takeishi Y. Technical aspects of cardiac PET/MRI. J Nucl Cardiol. 2018. Jun;25(3):1023–1028. DOI:10.1007/s12350-018-1237-4.
- IAEA Human Health Series No. 1. 2012. Quality assurance for PET and PET/CT systems. International Atomic Energy Agency; 2009.
- National Electrical Manufacturers Association. NEMA NU 2. Performance measurements of positron emission tomographs. National Electrical Manufacturers Association, Rosslyn, VA; 1994, 2001, 2007, 2012.
- Dahlbom M, Mawlawi O. PET/CT QA/QC and Acceptance Testing. American Association of Physicists in Medicine, presentation at Annual Meeting; 2012.
- ICRU Report 44. Tissue Substitutes in Radiation Dosimetry and Measurement. ICRU 1989.
- ICRP Report 48. Phantoms and Computational Models in Therapy, Diagnosis and Protection. ICRU 1993.
- Zhu Y, Geng C, Hung J, et al. Measurement and evaluation of quantitative performance of PET/CT images before a multicenter clinical trial. Sci Rep. 2018 Jun 13;8(1):9035. DOI:10.1038/s41598-018-27143-4.
- Matusiak K, Wasilewska-Radwańska M, Stepień A. Dynamic heart phantom for the quality control of SPECT equipment. Phys Med. 2008;24(2):112–116. DOI:10.1016/j.ejmp.2008.01.015)
- https://grab.uprp.pl/sites/Opisy/Miniaturki/Opisy/3104296.pdf (Patent information)
- www.biodex.com (Biodex Medical Systems)
- http://amide.sourceforge.net/ (AMIDE: Amide's a Medical Imaging Data Examiner)
- Slomka P, Pan T, Berman D, et al. Advances in SPECT and PET hardware. Prog Cardiovasc Dis. 2015;57(6):566–578. DOI:10.1016/j.pcad.2015.02.002.
- Slomka PJ, Berman DS, Germano G. New cardiac cameras: single-photon emission CT and PET. Semin Nucl Med. 2014;44:232–251. DOI:10.1053/j.semnuclmed.2014.04.003.
- Knight S, Min DB, Le VT, et al. Implementation of a cardiac PET stress program: comparison of outcomes to the preceding SPECT era. JCI Insight. 2018 May 3;3(9):pii: 120949. DOI:10.1172/jci.insight.120949.